Clinical Trial Update: Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravenous methylnaltrexone for prevention of postoperative ileus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Postoperative Ileus | Phase 2 | Status: COMPLETED